Condition
Pressure Ulcer, Buttock
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Completed2
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07193849Phase 4Recruiting
Zinc Oxide VS MEBO
NCT04168450Not ApplicableCompletedPrimary
Evaluation of Wheelchair In-Seat Activity Tracker
NCT04890678Not ApplicableCompleted
The Use of a Fully Automated Pulsating Support System (CuroCell® A4 CX20) in Pressure Ulcer Prevention and Treatment
NCT04266808Not ApplicableUnknown
Interactive Telehealth for Wheelchair Users
NCT03107143Not ApplicableUnknownPrimary
Study of TurnCare's Q-2 System on the Sacral Pressure Ulcer Prevention in High Risk Patients
Showing all 5 trials